LAZZARATO, Loretta
LAZZARATO, Loretta
SCIENZA E TECNOLOGIA DEL FARMACO
A NEW CLASS OF BISPHOSPHONATES WITH NO-DONOR PROPERTIES
2001-01-01 L. LAZZARATO
Amphiphile NO-donor antioxidants as polivalent drugs
2006-01-01 MARINI E; LAZZARATO L; CHEGAEV K; FRUTTERO R; GASCO A
BROAD SPECTRUM METALLO beta-LACTAMASES INHIBITORS: NEW TOOLS AGAINST CLINICALLY-RELEVANT CARBAPENEMASES
2022-01-01 Lazzarato, L.; Failla, M.; Gianquinto, E.; Bersani, M.; Bertarini, L.; Verri, A.; Vascon, F.; Sannio, F.; Verdirosa, F.; Beatrice, N.; De Luca, F.; Costi, M.P.; Cruciani, G.; Docquier, J.D.; Cendron, L.; Spyrakis, F.; Tondi, D.
Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives
2012-01-01 M. Bertinaria; M. A. A. G. Shaikh; C. Cena; B. Rolando; L. Lazzarato; R. Fruttero; A. Gasco; G. E. Rovati; C. Buccellati; V. Capra; A. Sala
EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY.
2019-01-01 Stefano Guglielmo, Marialessandra Contino, Chiara Riganti, Barbara Rolando, Loretta Lazzarato
GIFC-2018 - BOOK OF ABSTRACTS
2018-01-01 muntoni e, battaglia l, marini e, giorgis m, lazzarato l, salaroglio ic, riganti c, martina k
New class of NO-donor soluble aspirins
2012-01-01 Marini E.; Rolando B.; Lazzarato L.; Joseph S.; Fruttero R.
NEW CLASS OF NO-DONORS WITH BONE SELECTIVITY
2003-01-01 L. LAZZARATO; LOLLI M.L; BALBO S; DELEIDE G; FRUTTERO R
New NO-donor Bisphosphonates
2001-01-01 L. LAZZARATO; LOLLI M.L; DI STILO A; FRUTTERO R; GASCO A
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance.
2013-01-01 Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo
Nitrooxymethyl substituted analogues of Celecoxib and Rofecoxib
2007-01-01 BOSCHI D; CENA C; LAZZARATO L; MARINI E; FRUTTERO R.; GASCO A.
Nitrooxymethyl substituted analogues of celecoxib as potential antitumoral drugs with reduced cardiotoxicity
2008-01-01 Boschi D; Lazzarato L; Filieri A; Miglietta A; Bocca C; Fruttero R; Gasco A.
NO donor - melatonins: a new class of potential antiatherosclerosis agents
2005-01-01 CHEGAEV K; LAZZARATO L; GIORGIS M; CENA C; DI STILO A; FRUTTERO R; GASCO A; LUCINI V; PANNACI M
NO-Donor Cyanines As Potential Anti-Alzheimer Drugs
2011-01-01 Federico A.; Chegaev K.; Lazzarato L.; Marini E.; Fruttero R.; Gasco A.
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors
2010-01-01 Roberta Fruttero; Loretta Lazzarato; Konstantin Chegaev; Barbara Rolando; Donatella Boschi; Claudiu T. Supuran; Alessio Innocenti; Alberto Gasco
Novel amphiphilic nitric oxide releasing antioxidants: NMR spectroscopic study of their interaction with biomembrane models
2005-01-01 LOPEZ V; LAZZARATO L; CHEGAEV K; ROLANDO B; FRUTTERO R; GASCO A
NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY
2013-01-01 Konstantin Chegaev; Loretta Lazzarato; Barbara Rolando; Chiara Riganti; Roberta Fruttero; Alberto Gasco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A NEW CLASS OF BISPHOSPHONATES WITH NO-DONOR PROPERTIES | 2001 | L. LAZZARATO | |
| Amphiphile NO-donor antioxidants as polivalent drugs | 2006 | MARINI E; LAZZARATO L; CHEGAEV K; FRUTTERO R; GASCO A | |
| BROAD SPECTRUM METALLO beta-LACTAMASES INHIBITORS: NEW TOOLS AGAINST CLINICALLY-RELEVANT CARBAPENEMASES | 2022 | Lazzarato, L.; Failla, M.; Gianquinto, E.; Bersani, M.; Bertarini, L.; Verri, A.; Vascon, F.; Sannio, F.; Verdirosa, F.; Beatrice, N.; De Luca, F.; Costi, M.P.; Cruciani, G.; Docquier, J.D.; Cendron, L.; Spyrakis, F.; Tondi, D. | |
| Different multitarget approaches to manage coxibs associatedcardiovascular risk. Design and synthesis of new lumiracoxibderivatives | 2012 | M. Bertinaria; M. A. A. G. Shaikh; C. Cena; B. Rolando; L. Lazzarato; R. Fruttero; A. Gasco; G. E. Rovati; C. Buccellati; V. Capra; A. Sala | |
| EFFICIENTLY TARGETING DRUG EFFLUX THROUGH MODULATION OF P-GLYCOPROTEIN ACTIVITY BY SMALL MOLECULES: DESIGN, BIOLOGICAL AND COMPUTATIONAL STUDY. | 2019 | Stefano Guglielmo, Marialessandra Contino, Chiara Riganti, Barbara Rolando, Loretta Lazzarato | |
| GIFC-2018 - BOOK OF ABSTRACTS | 2018 | muntoni e, battaglia l, marini e, giorgis m, lazzarato l, salaroglio ic, riganti c, martina k | |
| New class of NO-donor soluble aspirins | 2012 | Marini E.; Rolando B.; Lazzarato L.; Joseph S.; Fruttero R. | |
| NEW CLASS OF NO-DONORS WITH BONE SELECTIVITY | 2003 | L. LAZZARATO; LOLLI M.L; BALBO S; DELEIDE G; FRUTTERO R | |
| New NO-donor Bisphosphonates | 2001 | L. LAZZARATO; LOLLI M.L; DI STILO A; FRUTTERO R; GASCO A | |
| Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. | 2013 | Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo | |
| Nitrooxymethyl substituted analogues of Celecoxib and Rofecoxib | 2007 | BOSCHI D; CENA C; LAZZARATO L; MARINI E; FRUTTERO R.; GASCO A. | |
| Nitrooxymethyl substituted analogues of celecoxib as potential antitumoral drugs with reduced cardiotoxicity | 2008 | Boschi D; Lazzarato L; Filieri A; Miglietta A; Bocca C; Fruttero R; Gasco A. | |
| NO donor - melatonins: a new class of potential antiatherosclerosis agents | 2005 | CHEGAEV K; LAZZARATO L; GIORGIS M; CENA C; DI STILO A; FRUTTERO R; GASCO A; LUCINI V; PANNACI M | |
| NO-Donor Cyanines As Potential Anti-Alzheimer Drugs | 2011 | Federico A.; Chegaev K.; Lazzarato L.; Marini E.; Fruttero R.; Gasco A. | |
| NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors | 2010 | Roberta Fruttero; Loretta Lazzarato; Konstantin Chegaev; Barbara Rolando; Donatella Boschi; Claudiu T. Supuran; Alessio Innocenti; Alberto Gasco | |
| Novel amphiphilic nitric oxide releasing antioxidants: NMR spectroscopic study of their interaction with biomembrane models | 2005 | LOPEZ V; LAZZARATO L; CHEGAEV K; ROLANDO B; FRUTTERO R; GASCO A | |
| NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY | 2013 | Konstantin Chegaev; Loretta Lazzarato; Barbara Rolando; Chiara Riganti; Roberta Fruttero; Alberto Gasco |